Sanjivani Paranteral Intrinsic Value

SANJIVIN • Healthcare
Current Stock Price
₹173.30
Primary Intrinsic Value
₹117.04
Market Cap
₹208.0 Cr
-52.6% Downside
Median Value
₹82.19
Value Range
₹52 - ₹117
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

SANJIVIN Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹117.04 ₹93.63 - ₹140.45 -32.5% EPS: ₹5.32, Sector P/E: 22x
Book Value Method asset ₹66.67 ₹60.00 - ₹73.34 -61.5% Book Value/Share: ₹33.33, P/B: 2.0x
Revenue Multiple Method revenue ₹106.67 ₹96.00 - ₹117.34 -38.4% Revenue/Share: ₹53.33, P/S: 2.0x
EBITDA Multiple Method earnings ₹69.32 ₹62.39 - ₹76.25 -60.0% EBITDA: ₹8.00Cr, EV/EBITDA: 10x
PEG Ratio Method growth ₹51.99 ₹46.79 - ₹57.19 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹82.19 ₹73.97 - ₹90.41 -52.6% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹93.33 ₹84.00 - ₹102.66 -46.1% ROE: 20.0%, P/E Multiple: 14x
Graham Defensive Method conservative ₹63.17 ₹56.85 - ₹69.49 -63.5% EPS: ₹5.32, BVPS: ₹33.33
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check SANJIVIN share price latest .

Valuation Comparison Chart

SANJIVIN Intrinsic Value Analysis

What is the intrinsic value of SANJIVIN?

Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sanjivani Paranteral (SANJIVIN) is ₹82.19 (median value). With the current market price of ₹173.30, this represents a -52.6% variance from our estimated fair value.

The valuation range spans from ₹51.99 to ₹117.04, indicating ₹51.99 - ₹117.04.

Is SANJIVIN undervalued or overvalued?

Based on our multi-method analysis, Sanjivani Paranteral (SANJIVIN) appears to be trading above calculated value by approximately 52.6%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 4.86 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.95 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 20.0% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 15.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 0.82x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹12 Cr ₹1 Cr Positive Free Cash Flow 7/10
March 2024 ₹-11 Cr ₹-17 Cr Negative Cash Flow 3/10